REDEFINING ALZHEIMER’S DISEASE THROUGH MODERN BIOTECHNOLOGY; FROM MOLECULAR PATHOGENESIS TO INNOVATIVE THERAPEUTICS AND DIAGNOSTIC FRONTIERS. (2025). Journal of Medical & Health Sciences Review, 2(4). https://doi.org/10.65035/w1y9ey43